Page 51 - Read Online

progression and prognosis of gastric cancer: a microRNA 69. Koga Y, Yasunaga M, Takahashi A, Kuroda J, Moriya Y,
expression analysis. Lancet Oncol 2010;11:136-46. Akasu T, Fujita S, Yamamoto S, Baba H, Matsumura Y.
53. Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, Zhao C, MicroRNA expression profi ling of exfoliated colonocytes
Tao Y, Xu W. Circulating miR-17-5p and miR-20a: molecular isolated from feces for colorectal cancer screening. Cancer
markers for gastric cancer. Mol Med Rep 2012;5:1514-20. Prev Res (Phila) 2010;3:1435-42.
54. Yang Q, Jie Z, Cao H, Greenlee AR, Yang C, Zou F, 70. Kalimutho M, Di Cecilia S, Del Vecchio Blanco G, Roviello F,
Jiang Y. Low-level expression of let-7a in gastric cancer Sileri P, Cretella M, Formosa A, Corso G, Marrelli D,
and its involvement in tumorigenesis by targeting RAB40C. Pallone F, Federici G, Bernardini S. Epigenetically silenced
Carcinogenesis 2011;32:713-22. miR-34b/c as a novel faecal-based screening marker for
55. Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, colorectal cancer. Br J Cancer 2011;104:1770-8.
Choi IJ, Munroe DJ, Green JE. miRNA signature associated 71. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED,
with outcome of gastric cancer patients following Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG,
chemotherapy. BMC Med Genomics 2011;4:79. Calin GA, Croce CM, Harris CC. MicroRNA expression
56. Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, Tang H. profi les associated with prognosis and therapeutic outcome in
MicroRNA-181b targets cAMP responsive element colon adenocarcinoma. JAMA 2008;299:425-36.
binding protein 1 in gastric adenocarcinomas. IUBMB Life 72. Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T.
2012;64:628-35. Clinicopathological and prognostic value of microRNA-21
57. Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, and microRNA-155 in colorectal cancer. Oncology
2010;79:313-20.
Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M.
Down-regulation of miR-125a-3p in human gastric cancer 73. Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A,
and its clinicopathological signifi cance. Int J Oncol Rupert K, Ludvikova M, Babuska V, Holubec L Jr, Cerny R.
2012;40:1477-82. Relevance of miR-21 and miR-143 expression in tissue
58. Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D, Tian Q, samples of colorectal carcinoma and its liver metastases.
Cancer Genet Cytogenet 2010;200:154-60.
Wang Q, Wang C, Long Z, Zhou Y, Cao X, Du C, Shi Y,
He X. MicroRNA-409 suppresses tumour cell invasion and 74. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ,
metastasis by directly targeting radixin in gastric cancers. Hansen U, Brunner N, Baker A, Moller S, Nielsen HJ. High
Oncogene 2012;31:4509-16. levels of microRNA-21 in the stroma of colorectal cancers
59. Yang SM, Huang C, Li XF, Yu MZ, He Y, Li J. miR-21 predict short disease-free survival in stage II colon cancer
patients. Clin Exp Metastasis 2011;28:27-38.
confers cisplatin resistance in gastric cancer cells by regulating
PTEN. Toxicology 2013;306:162-8. 75. Diaz R, Silva J, Garcia JM, Lorenzo Y, Garcia V, Pena C,
Rodriguez R, Munoz C, Garcia F, Bonilla F, Dominguez G.
60. Deng H, Guo Y, Song H, Xiao B, Sun W, Liu Z, Yu X, Xia T, Deregulated expression of miR-106a predicts survival in
Cui L, Guo J. MicroRNA-195 and microRNA-378 mediate human colon cancer patients. Genes Chromosomes Cancer
tumor growth suppression by epigenetical regulation in gastric 2008;47:794-802.
cancer. Gene 2013;518:351-9. 76. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL,
61. Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li K, Zhou L, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ,
Sun Y, Li M, Zhou J, An Y, Wu K, Nie Y, Fan D. miR-508-5p Kruhoffer M, Laurberg S, Kauppinen S, Orntoft TF,
regulates multidrug resistance of gastric cancer by targeting Andersen CL. Diagnostic and prognostic microRNAs
ABCB1 and ZNRD1. Oncogene 2014;33:3267-76. in stage II colon cancer. Cancer Res 2008;68:6416-24.
62. Hu J, Fang Y, Cao Y, Qin R, Chen Q. miR-449a Regulates 77. Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F,
proliferation and chemosensitivity to cisplatin by targeting Shibata K, Ishii H, Doki Y, Kuwano H, Mori M. MicroRNA
cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci miR-125b is a prognostic marker in human colorectal cancer.
2014;59:336-45. Int J Oncol 2011;38:1437-43.
63. Zhao X, Yang L, Hu J. Down-regulation of miR-27a might 78. Drebber U, Lay M, Wedemeyer I, Vallbohmer D,
inhibit proliferation and drug resistance of gastric cancer cells. Bollschweiler E, Brabender J, Monig SP, Holscher AH,
J Exp Clin Cancer Res 2011;30:55. Dienes HP, Odenthal M. Altered levels of the onco-microRNA
64. Lieberman D. Progress and challenges in colorectal 21 and the tumor-supressor microRNAs 143 and 145 in
cancer screening and surveillance. Gastroenterology advanced rectal cancer indicate successful neoadjuvant
2010;138:2115-26. chemoradiotherapy. Int J Oncol 2011;39:409-15.
65. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, 79. Akcakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM,
Ng SS, Sung JJ. Differential expression of microRNAs in Xie H, Lindforss U, Olivecrona H, Lui WO. miR-185 and
plasma of patients with colorectal cancer: a potential marker miR-133b deregulation is associated with overall survival and
for colorectal cancer screening. Gut 2009;58:1375-81. metastasis in colorectal cancer. Int J Oncol 2011;39:311-8.
66. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma 80. Karaayvaz M, Pal T, Song B, Zhang C, Georgakopoulos P,
microRNAs are promising novel biomarkers for early Mehmood S, Burke S, Shroyer K, Ju J. Prognostic signifi cance
detection of colorectal cancer. Int J Cancer 2010;127:118-26. of miR-215 in colon cancer. Clin Colorectal Cancer
67. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, 2011;10:340-7.
Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W. 81. Yu G, Tang JQ, Tian ML, Li H, Wang X, Wu T, Zhu J,
Circulating plasma MiR-141 is a novel biomarker for Huang SJ, Wan YL. Prognostic values of the miR-17-92
metastatic colon cancer and predicts poor prognosis. PLoS cluster and its paralogs in colon cancer. J Surg Oncol
One 2011;6:e17745. 2012;106:232-7.
68. Link A, Balaguer F, Shen Y, Nagasaka T, Lozano JJ, 82. Faber C, Horst D, Hlubek F, Kirchner T. Overexpression of
Boland CR, Goel A. Fecal MicroRNAs as novel biomarkers Dicer predicts poor survival in colorectal cancer. Eur J Cancer
for colon cancer screening. Cancer Epidemiol Biomarkers 2011;47:1414-9.
Prev 2010;19:1766-74. 83. Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M,

152 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦